Ureter Cancer
📧 Sign up to get email alerts when something new happens for Ureter Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study [Phase 2]
Phase 2 trial evaluating gemcitabine to prevent intravesical recurrence of urothelial cancer in patients with upper tract urothelial cancer …
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases [Phase 2]
Phase 2 trial comparing denosumab with standard treatment in urothelial cancer patients with bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer [Phase 2]
Phase 2 clinical trial evaluating erlotinib hydrochloride in patients with muscle-invasive or recurrent urothelial cancer has completed, wit…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride and eribulin mesylate in advanced or unresectable bladder, ureter, and urethral …
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and gemcitabine with or without vandetanib as first-line therapy for locally advanced or metastatic uri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma [Phase 3]
A Phase 3 trial comparing four vs six cycles of cisplatin-based chemotherapy in metastatic urothelial carcinoma is ongoing/unknown status.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum [Phase 2]
This is a completed Phase 2 clinical trial evaluating Genexol-PM in patients with advanced urothelial cancer (bladder or ureter cancer) prev…